Mucogel Suspension – 125ml

Uses

• Ulcers
• Heartburn
• Dyspepsia
• Hyperphosphatemia in patients with kidney disease
• Constipation
• Mucogel Suspension may also be used for purposes not listed here.

Relcer Oral Gel is an allopathic formulation indicated to be used as an antacid or acid reflux balancer. The cream is recommended to be used for only topical uses. Key Ingredients:

Aluminium hydroxide

Magnesium hydroxide

Activated dimethicone

Deglycyrrhized licorice

Key Benefits:

The gel can be used for managing symptoms of gastritis, flatulence, acidity, dyspepsia, peptice ulcers and heartburn

It helps to provide relief from acid reflux immediately

The major ingredient of the gel helps the neutralize the acid balance in the body post meals

The formulation provides immediate relief and is easy to apply

Directions For Use:

Use Relcer Oral Gel as directed by the physician

Safety Information:

Read the label carefully before use

Oracure oral gel Uses

• Pain caused by mouth ulcers
• Dental plaque
• Skin infections
• Gingivitis
• Eye infections
• Periodontitis
• Numbness
• Pain caused by denture irritation
• Pain caused by anal or rectal problems
• Before minor surgeries as local anesthetic
• Oracure oral gel may also be used for purposes not listed here.

Oracure oral gel Working, Mechanism of Action and Pharmacology

• Killing the bacteria.
• Stopping the sensation of pain by acting on peripheral nerves in the body.

• For the treatment of folate-deficient megaloblastic anaemia due to malnutrition, malabsorption syndromes (such as coeliac disease or sprue) and increased utilisation as in pregnancy. It should not be used alone in undiagnosed megaloblastic anaemia including in infancy, pernicious anaemia or macrocytic anaemia of unknown aetiology, unless administered with adequate amounts of hydroxocobalamin.
• For the prophylaxis of drug induced folate deficiency e.g., caused by administration of phenytoin, phenobarbital and primidone. (See section 4.5).
• For the prophylaxis against folate deficiency in chronic haemolytic states or in renal dialysis.
• For the prevention of neural tube defects for woman planning a pregnancy and known to be at risk

• Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
• Long-term folate therapy is contraindicated in any patient with untreated cobalamin deficiency. This can be untreated pernicious anaemia or other cause of cobalamin deficiency, including lifelong vegetarians. In elderly people, a cobalamin absorption test should be done before long-term folate therapy. Folate given to such patients for 3 months or longer has precipitated cobalamin neuropathy. No harm results from short courses of folate
• Folic acid should never be given alone in the treatment of Addisonian pernicious anaemia and other vitamin B₁₂deficiency states because it may precipitate the onset of subacute combined degeneration of the spinal cord
• Folic acid should not be used in malignant disease unless megaloblastic anaemia owing to folate deficiency is an important complication.

• Patients with vitamin B₁₂deficiency should not be treated with folic acid unless administered with adequate amounts of hydroxocobalamin, as it can mask the condition but the subacute irreversible damage to the nervous system will continue. The deficiency can be due to undiagnosed megaloblastic anaemia including in infancy, pernicious anaemia or macrocytic anaemia of unknown aethiology or other cause of cobalamin deficiency, including lifelong vegetarians.
• Caution should be exercised when administering folic acid to patients who may have folate dependent tumours.
• This product is not intended for healthy pregnant women where lower doses are recommended, but for pregnant women with folic acid deficiency or women at risk for the reoccurrence of neural tube defects.
• This product contains lactose monohydrate. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose – galactose malabsorption should not take this medicine